Deals
Bausch + Lomb Up in Debut After Below-Range $630 Million IPO
- Canadian contact-lens maker climbs 11% on first day of trading
- Business is first of two being spun out of Bausch Health
Photographer: Suzanne Plunkett/Bloomberg
This article is for subscribers only.
Canada’s Bausch + Lomb Corp. rose 11% in its trading debut after its initial public offering priced below a marketed range to raise $630 million.
Bausch + Lomb, the first of two businesses being spun out by Bausch Health Cos., was seen as a test of whether a stable, profitable business could help break the ice for dozens of companies waiting in the wings to go public.